Experts review BTK inhibitor treatment recommendations in B-cell malignancies, like CLL, MCL, MZL, and WM, in these downloadable slides from CCO
Review key BTK inhibitor results in CLL, MCL, MZL, and Waldenstrom macroglobulinemia with this set of commentaries from CCO
Get a preview of key studies at ASCO 2020 from experts in both solid tumors and hematologic malignancies from Clinical Care Options
In this slideset from Clinical Care Options, experts provide insights for nurses on managing toxicities associated with CAR T-cell therapy.
You are accessing CCO's educational content today as a Guest user.
If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.